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Abstract
Background: Older adults are the fastest growing segment of the world‘s population. Recent evidence indicates
that excessive sitting time is harmful to health, independent of meeting the recommended moderate to vigorous
physical activity (PA) guidelines. The SITLESS project aims to determine whether exercise referral schemes (ERS) can
be enhanced by self-management strategies (SMSs) to reduce sedentary behaviour (SB), increase PA and improve
health, quality of life and function in the long term, as well as psychosocial outcomes in community-dwelling older
European citizens from four countries, within a three-armed pragmatic randomised controlled trial, compared with
ERS alone and also with general recommendations about PA.
Methods: A total of 1338 older adults will be included in this study, recruited from four European countries
through different existing primary prevention pathways. Participants will be randomly allocated into an ERS of
16 weeks (32 sessions, 45–60 min per session), ERS enhanced by seven sessions of SMSs and four telephone
prompts, or a control group. Outcomes will be assessed at baseline, month 4 (end of ERS intervention), month 16
(12 months post intervention) and month 22 (18 months post intervention). Primary outcomes will include
measures of SB (time spent sedentary) and PA (counts per minute). Secondary outcomes will include muscle and
physical function, health economics’ related outcomes, anthropometry, quality of life, social networks, anxiety and
depressive symptoms, disability, fear of falling, executive function and fatigue. A process evaluation will be
conducted throughout the trial. The full analysis set will follow an intention-to-treat principle and will include all
randomised participants for whom a baseline assessment is conducted. The study hypothesis will be tested with
mixed linear models with repeated measures, to assess changes in the main outcomes (SB and PA) over time
(baseline to month 22) and between study arms.
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Discussion: The findings of this study may help inform the design and implementation of more effective
interventions to reduce SB and increase PA levels, and hence improve long-term health outcomes in the older
adult population. SITLESS aims to support policy-makers in deciding how or whether ERS should be further
implemented or restructured in order to increase its adherence, impact and cost-effectiveness.
Trial registration: ClinicalTrials.gov, NCT02629666. Registered 19 November 2015.
Keywords: Sedentary behaviour, Physical activity, Behaviour change, Older adults, Self-management strategies
Background
Older adults are the fastest growing segment of the
world’s population [1]. Although prolonging life remains
an important public health goal, of even greater signifi-
cance is the preservation of functional and cognitive per-
formance, and of the capacity to live independently
during late life.
Being insufficiently active is associated with increased
risk for major non-communicable diseases and all-cause
mortality, which is related to increased healthcare costs
[2–4]. It is estimated that people aged 65 years and over
account for 30–40% of the total healthcare spend across
Europe [5]. The burden of disease attributable to being
insufficiently physically active has recently been esti-
mated to be responsible for 6–9% of the total deaths
worldwide and accounts for as many as 5.3 million
deaths per year [2, 6]. In this context, it is estimated that
across all ages, 31% of the global population do not meet
current physical activity (PA) recommendations estab-
lished by the World Health Organization (WHO) [7].
In the last decade, growing evidence indicates that ex-
cessive sitting time may be harmful to health, independ-
ent of meeting the recommended moderate-to-vigorous
PA guidelines [8–13]. Time spent in sedentary behaviour
(SB)—defined as any waking behaviour characterised by
energy expenditure ≤ 1.5 Metabolic Equivalent Tasks
(MET) while in a sitting or reclining posture [14]—has
increased substantially over the last three decades [15].
Older adults are the most sedentary segment of society,
as many spend over 75% of their waking day in SB [16].
Current evidence suggests that prolonged SB is associ-
ated with increased rates of several chronic diseases and
all-cause mortality in older adults [17–20].
Primary care is a key setting for the promotion of PA.
The most common model of PA promotion in primary
care involves exercise referral schemes (ERS), whereby a
general practitioner or another member of the primary
care team (e.g. physiotherapist, nurse or pharmacist)
identifies and refers insufficiently active individuals to a
third-party service (often a sports centre or leisure facil-
ity) to conduct an exercise program [21, 22]. Despite re-
cent studies showing the health benefits of such
programs, most studies also demonstrate that such gains
are rarely sustained [21]. Recent guidelines also advocate
the use of established behavioural change techniques
(BCTs) to promote increased levels of PA [23]. Among
those, self-management strategies (SMSs) may success-
fully improve involvement in exercise in specific popula-
tions, increasing levels of daily PA, enhancing quality of
life, improving mental health, producing greater confi-
dence and increasing power to act [24].
Research focusing on interventions to reduce SB has
only begun to emerge in the last five years and there
have been few studies conducted in older adults. Recent
studies targeting reduced SB in this population have in-
cluded BCTs such as goal setting, instruction on how to
perform the behaviour, self-monitoring and feedback of
behaviour, prompts/cues and restructuring the physical
environment [25–29]. Moderate quality evidence indi-
cates that specific interventions have the potential to re-
duce SB in older adults [30]. These findings are
supported by systematic reviews focusing on adults [31–
33]. As far as we know, no previous studies have
assessed the effects of an exercise-based intervention en-
hanced by SMSs addressing both increased daily PA and
a reduction of SB in older adults.
Therefore, the SITLESS project aims to determine
whether ERS can be enhanced by SMSs to reduce SB, in-
crease PA and improve health, quality of life and func-
tion in the long term (22 months), as well as
psychosocial outcomes in community-dwelling older
European citizens from four countries, within a three-
armed pragmatic randomised controlled trial (RCT),
compared with ERS alone and also with general recom-
mendations about PA. SITLESS will also collect health
economics’ related outcomes, data on healthcare systems
and community costs to perform cost-effectiveness ana-
lyses. SITLESS has the purpose to support policy-makers
in deciding how or whether ERS should be further im-
plemented or restructured in order to increase its adher-
ence, impact and cost-effectiveness.
Methods/design
Study design
The present study protocol describes a multi-centre
pragmatic three-armed parallel RCT. Outcomes will be
assessed at baseline, month 4 (end of intervention),
month 16 (12 months post intervention) and month 22
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(18 months post intervention) which will be the main
outcome assessment. The study protocol has been devel-
oped based on the Standard Protocol Items: Recommen-
dations for Interventional Trials (SPIRIT) guidelines
[34]. The study design was approved by the Ethics and
Research Committee of each intervention site: The Eth-
ics and Research Committee of Ramon Llull University
(Fundació Blanquerna, Spain), The Regional Committees
on Health Research Ethics for Southern Denmark (Uni-
versity of Southern Denmark, Denmark), Office for Re-
search Ethics Committees in Northern Ireland
(ORECNI) (Queen’s University of Belfast) and the Eth-
ical Review Board of Ulm University (Ulm, Germany).
Participation is voluntary and all participants will be
asked to sign informed consent before the start of the
study (see Additional file 1).
SITLESS, as a Responsible Research and Innovation
project, has created guidance for the involvement of
stakeholders in the project from the onset. Accordingly,
four local advisory boards were created, one on each
intervention site (Barcelona, Odense, Belfast, Ulm) and
are periodically involved in the study. They comprise
primary healthcare and sport professionals, older adults,
policy-makers and other local stakeholders of relevance
(e.g. health insurance, where relevant). A gender expert
linked to the European project EGERA is part of the ad-
visory board of Barcelona.
Participants
A total of 1338 participants (randomised into three
intervention groups of 446 participants) will be included
in this study and recruited in four intervention sites
(Barcelona, Odense, Belfast, Ulm). Each intervention site
will be in charge of recruiting 335 participants and will
collect relevant descriptive information regarding partic-
ipants’ demographic characteristics (e.g. age, gender,
marital status, living arrangements and educational
background). Barcelona is the largest site of the study
with 1,602,000 inhabitants in 2014, followed by Belfast
with 333,871 at the 2015 census. Odense and Ulm have
less than 200,000 inhabitants. Outcome measures will be
also analysed to detect any between-site differences.
Participants are eligible if they are: (1) aged 65 years or
above; (2) community-dwelling; (3) able to walk without
the help of another person for at least 2 min with or
without a walking aid; (4) have no major physical limita-
tions as shown by a score on the Short Physical Per-
formance Battery (SPPB) of 4 or above [35]; (5)
insufficiently active as determined by the following
screening question: ‘Do you perform regular physical ac-
tivity (PA) for at least 30 minutes five or more days of
the week (referring only to PA that makes the participant
become out of breath while doing it or such that it
doesn’t allow him/her to maintain a conversation while
doing the activity) (do not count regular walking)’; and/
or (6) report spending long periods of time in SB by an-
swering affirmatively to the question: ‘For most days, do
you feel you sit for too long (6–8 hours or more a day)?
Some examples might include when watching TV, work-
ing at the computer / laptop or when doing sitting-based
hobbies such as sewing’ [17]. Participants will be ex-
cluded if they: (1) have moderate or severe dementia
when screened with the six-item screener to identify
cognitive impairment, using a cutoff of three or more er-
rors [36]; (2) have a medical condition which may inter-
fere with the study design; (3) have unstable medical
conditions (e.g. elevated blood pressure after medication,
uncontrolled hypertension) or symptomatic cardiovascu-
lar diseases that contraindicates participation in PA; (4)
expect not to be able to attend 75% of the ERS sessions
throughout the intervention; and (5) have participated in
an ERS in the six months prior to their entry into the
study.
Sample size
A sample size of 1338 participants (randomised to one
of three groups of 446 participants) will be needed to de-
tect a moderate effect size of 30 daily counts per minute
(CPM) in a two-sided test, at a power of 80% and an α
of 0.05, a common standard deviation of 139 of the
mean and a 24% dropout rate. A change of 30 CPM is
considered a measurable moderate effect size in this
population, assessed with ActiGraph GT3X+, and 139 is
the standard deviation for CPM found in the literature
[37]. The present sample size allows estimation of over-
all efficacy.
Sample size computations were conducted with online
software GRANMO (http://www.imim.es/ofertadeser-
veis/software-public/granmo/; last accessed on 21/7/
2014).
Study procedure
Recruitment strategies will be site-specific according to
the different existing primary prevention pathways in
each country. Primary care centres and other health-
related centres of each intervention site will be informed
and asked to participate. The research team will inform
professionals about the background and the aims of the
study. Health professionals who volunteer to participate
will be further given all information regarding eligibility
criteria and the recruitment strategy. Posters, flyers, news-
papers, radio broadcasts and social media outlets will also
be used to advertise the study and as additional recruitment
strategies (Additional file 2: shows the SPIRIT checklist).
Health professionals or the local research team will as-
sess interested individuals against the eligibility criteria.
Eligible participants will have their name, gender, date of
birth and phone number recorded, while individuals
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deemed ineligible or that do not want to participate will
have their reason for declining as well as their gender
and age recorded.
Randomisation and blinding
During the first meeting, a researcher will explain the
trial to interested individuals, give them an information
sheet about the study and obtain their written informed
consent (see Additional file 1). Participants will then be
scheduled for the baseline testing session. After the
baseline assessment, each participant will be centrally
randomised to one of the three study groups (e.g. ERS +
SMS, ERS or the control group), using a computer-
based random-block randomisation scheme, clustering
by couples when cohabitees wish to be enrolled together.
Concealed randomisation will be conducted centrally at
FSiE, after each participant has been included in the
study, assigned an identification code and has completed
the study baseline assessment.
The trial has an open design with blind assessment of
outcomes. Researchers conducting the baseline assess-
ments will be blind to group allocation. The statistician
will also be blind to group allocation until completion of
the statistical analysis. Participants will be asked not to
reveal group allocation when undergoing follow-up mea-
surements, as researchers conducting follow-up mea-
surements will be blind to group allocation. To assess
the extent to which blinding has been preserved, re-
searchers will record the number of cases in which allo-
cation was revealed.
Study interventions
A complex intervention [38] consisting of a PA program
with self-management strategies (ERS + SMS) will be de-
livered in primary care or community settings in urban
areas of Barcelona (Spain), Odense (Denmark), Belfast
(UK) and Ulm (Germany) (see Table 1). All trainers in
charge of conducting both intervention groups will
undergo a standardised training.
Physical activity intervention (ERS)
Participants will undergo a 16-week PA program, con-
sisting of two sessions per week (45–60 min each ses-
sion). Participants will be asked to perform the activity
at a moderate-to-vigorous intensity (according to each
individual’s fitness levels) during the main part of each
session. Intensity will be estimated using the modified
Borg Scale of Perceived Exertion [39] (e.g. moderate-
intensity activity will be considered 4–6 and vigorous-
intensity activity will be 7–9) or with training loads (i.e.
ankle weights and dumbbells) corresponding to 70–80%
of one repetition maximum, adjusted progressively dur-
ing the training period.
The ERS program will be based on a combination of
aerobic, strength-based and balance activities. Aerobic
training may include walking, rowing, using an elliptical
trainer, cycling, fitness/water aerobics, Nordic walking,
swimming, dancing and/or any other activity such as
games which increase heart rate and respiratory fre-
quency. During the first week, these activities will be
performed at a moderate intensity, with bout duration
based on each individual aerobic level. Progression will
include increasing the duration and/or the intensity (e.g.
increasing resistance on the bike ergometer or increasing
walking speed on Nordic walking) up to a maximum of
9 of the same Borg Scale. The intervention will be tai-
lored for the participants with a low functional level
(score of 4–6 of the SPPB), in which more strength
training will be performed.
Lower-body strength exercises will include functional
tasks such as rising from a chair, stair climbing, knee
bends, floor transfer, walking, lunges, leg squat, leg exten-
sion, leg flexion, calf raise, lower back and abdominal curl
using ankle weights, elastic bands, training devices (e.g.
leg press), free weights or any other material available (e.g.
water bottles or sand sacks). Upper-body exercises may in-
clude pulldowns, low row, chest press, shoulder press and
biceps curl. The first session will be used to calculate the
baseline intensity. The first two weeks of the intervention
will be used as familiarisation, with the focus on technique
of the different exercises. Following the two-week period,
training intensity will be individually calculated by the 4–8
repetition maximum method (i.e. maximum number of
repetitions to failure between 4 and 8) for each exercise
using different training tools devices (e.g. fixed weights
machine, free weights, elastic bands) and body weight (e.g.
loaded sit-to-stand, squats, lunges). Lower-body exercises
will be performed explosively (e.g. as rapid as possible)
during the concentric phase of the movement and con-
trolled during the eccentric phase.
Balance-based exercises will focus on functional activ-
ities. Balance activities will be designed to challenge the
visual (e.g. eyes open/closed), vestibular (e.g. move head)
and somatosensory (e.g. stand on foam) systems. Static
balance will consist of two-leg and one-leg balance with
toes or heels raised and tandem standing with eyes open
or closed on different surfaces. When training dynamic
balance, activities such as walking on different surfaces,
with varied elevations, and performing a dual task (cog-
nitive and functional task such as catching, throwing
and reaching), incorporating different gait patterns (e.g.
narrow walking, longer strides, zigzag walking) and vari-
ations in gait speed, will be performed. Balance exercises
will include function-focused activities such as walking
with obstacles while wearing standard sunglasses (worn
over corrective lenses as needed) to mimic a semi-dark
environment, walking while carrying a package that
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obstructed the view of the feet and walking while picking
up objects from the floor. Initially the participants will per-
form one or two sets of 6–8 repetitions of each exercise;
the number of repetitions will be increased when a partici-
pant is able to complete eight repetitions showing no diffi-
culty; the maximum number of repetitions will be 20.
Three sets of exercises of increasing complexity will be de-
signed; when an easier step will be achieved without assist-
ance, the individual will be asked to perform the next more
complex set of exercises.
Participants will be encouraged to report any negative
sign or symptom resulting from the exercises during the
sessions. A brief summary on the ERS and SMSs interven-
tions can be found in Table 1.
ERS + SMS sessions
In order to fully inform the development of the SMSs
intervention, a number of preliminary steps were carried
out. A systematic review of interventions which aimed
to reduce SB in older adults was undertaken to identify
the components of these interventions, particularly
BCTs. Once these were established, each intervention
site conducted focus groups with older adults in order
to get their opinions on the proposed BCTs which would
be utilised in the SMSs intervention. On completion of
both these tasks, and guided by social-cognitive theory,
an initial logic model was developed to help determine
how different intervention components (i.e. inputs)
might have an impact on the proposed study outcomes
(e.g. SB, PA, quality of life and functional capacity). The
initial SMSs intervention was tested by each intervention
site as part of a feasibility study before it was refined for
the final SITLESS trial. SMSs training materials were de-
veloped and workshops were conducted by each partner
to help fully explain the SMSs intervention to the in-
structors. Monitoring and support for the SMSs
Table 1 General information of the ERS and SMS interventions
Name of
the
program
Program components Training responsible Duration General structure of each session
ERS
intervention
Aerobic training. Strength-
based/ endurance exercises.
Balance-based functional
exercises. Flexibility exercises.
Specially trained PA specialist:
physical therapist; sport
professional/trainer;
ergotherapist with specific
health qualification. Sessions
will be always performed under
the supervision of the same
trainer.
16 weeks. Two sessions per
week of 45–60 min. Ask each
participant to perform a third
session on their own such as a
30-min walk. The intervention
will be conducted in an indoor
primary-care or sports facility.
Municipality facilities (e.g. activity
centres for older adults).
All training sessions will begin
with a 5–10 min warm-up
focusing on social and physical
interactions. Followed by 35 min
of different exercises adapted to
each individual’s functional level
(according to the participants’
SPPB scorea). All training sessions
will end with cool-down
(breathing exercises and
stretching for 5–10 min.
SMS
intervention
Raising awareness on
differences, associations, risks
and benefits of SB and PA.
Setting personal activity goals
(long-term achievement goals).
Enhancing motivation.
Goal-setting focusing separately
on SB and PA. Self-monitoring
(pedometer and activity diary).
External monitoring (instructor).
Problem-solving according to
the IDEA.b Social influence and
social support. Raising
awareness on facilitators and
barriers of PA and SB at home
and neighbourhood.
Environmental signposting.
The same specialist for the ERS
intervention.
Total of 30 weeks. 1 one-to-one
session (week 1; 40 min). 6
group-based sessions (weeks 3,
4, 5, 7, 9 and 11; 45–60 min). 4
telephone calls (weeks 15, 20, 25
and 30; 20 min).
The SMS sessions include the
following activities: introducing
the project to the participant,
developing a rapport, setting a
meaningful long-term goal to
be achieved at the end of the
intervention, identifying
facilitators and barriers of PA
and SB at home and
neighbourhood in a group
dynamic, environmental
signposting to help engaging
participants in local
opportunities to do PA, checking
daily step counts registered in
the activity diary and setting
individual goals to increase steps
or other physical activities, set-
ting individual goals to reduce
siting time set choosing
recommendations (SITLESS tips)
for decreasing SB, problem-
solving techniques to overcome
barriers to being less sedentary
and more active according to
the IDEAb problem-solving.
aTotal SPPB score ranges from 0 (worst performance) to 12 (best performance); participants will be classified into three different functional performance levels
according to the results obtained: low = 4–6; medium = 7–9; high functional level = 10–12 points
b IDEA Identifying the problem, Develop a list of solutions, Evaluate the solutions and Analyse how the plan worked
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instructors is planned on a monthly basis using a mix-
ture of face-to-face meetings and teleconferences.
Participants randomised to this group will take part in
a local ERS combined with SMS intervention lasting
30 weeks in total. Both the ERS and SMS sessions will
be led by suitably qualified fitness instructors who have
been previously trained regarding the SMS intervention.
There will be 11 SMS sessions: one taking place before
the ERS intervention, seven during the ERS intervention
and three after the ERS. BCTs will be used to guide the
structure and content of the sessions [40]. These ses-
sions will consist of a one-to-one session, six group-
based sessions in local leisure / community centres and
four telephone calls to offer additional support to the
participants and to find how they are getting on with the
SMS intervention. The SMS sessions will be structured
as listed below.
One-to-one visit (Familiarisation Stage): the main aims
of the one-to-one visit will be to introduce the SMSs
intervention and materials to the participant and to start
developing a rapport. The participant will be given an
information booklet which will give further details on SB
and some ideas on how to sit less and be more active
(i.e. SITLESS tips). The participant will also be given a
Yamax DigiWalker SW-200 pedometer to wear during
the course of the SMSs intervention and will be shown
how to put this on by the instructor (the participant in-
formation booklet will contain instructions on how to
use the pedometer). The participant will be given an ac-
tivity diary to use during the duration of the SMSs inter-
vention to monitor their daily step counts, weekly time
in PA / exercise and use of SITLESS tips. This will also
allow them to monitor their daily step counts and
weekly time in PA / exercise during the first three weeks
of the intervention in order to develop baseline readings
before the first group-based session. The final task will
be to establish long-term functional goals that the par-
ticipant would like to achieve in the months after com-
pleting the intervention. The one-to-one visit is
expected to last approximately 50 min.
Six group-based sessions in the local leisure or com-
munity centre (Ramping and Maintenance Stages): the
main aims of the group-based sessions will be to retrieve
the participants’ step counts and weekly time in PA / ex-
ercise recorded in their activity diaries and their use of
SITLESS tips as well as agreeing on participants’ goals
for the following weeks. The participants will be encour-
aged to gradually increase their daily step counts, weekly
time in PA / exercise and their use of the SITLESS tips.
Each group-based session will also cover a specific
theme such as goal-setting, identifying barriers and facil-
itators for PA and SB in the neighbourhood and at
home, environmental signposting and problem-solving
techniques. It is hoped that these sessions will act as an
opportunity to improve participants’ motivation and in-
crease the level of social support to sitting less and being
more active. Each group-based session is expected to last
approximately 45–60 min.
Four telephone calls (Adherence Stage): the main aims
of the telephone calls are to provide motivational sup-
port and advice to participants to sit less and be more
active as well as trying to understand and support partic-
ipants to maintain their goals (daily step counts, weekly
time in PA / exercise and SITLESS tips). Each telephone
call is expected to last no more than 20 min.
Control group (CG)
Researchers will give to all participants during the first
informative meeting (prior assessment) a written general
booklet standardised across sites with the WHO recom-
mendation regarding PA regular practice for health.
During the intervention, a health advice meeting with
standardised topics about healthy lifestyle and feedback
on some outcomes will be held twice in the Primary
Health Centre (at week 5 and at week 11). Researchers
will send a letter or make a phone call prior to the next
assessment.
Outcome assessment
The ERS group will take 16 weeks and the ERS + SMS
group will take 30 weeks (including the four phone calls)
(see Fig. 1). Assessments will be conducted by the same
assessors at the following time points: T0 = baseline pre-
intervention, T1 = at month 4 post intervention, T2 = at
month 16 (12 months after the end of the intervention),
and T3 = at month 22 (18 months after the end of the
intervention). (Fig. 2 shows the SPIRIT figure). All re-
searchers in charge of conducting the assessments will
undergo a standardised training session.
Personal information regarding age, gender, marital
status, living arrangement, educational background,
medical conditions, and smoking and alcohol habits will
be collected at baseline.
The costs of the interventions (ERS, SMS and the CG
intervention) will be also collected by a structured
questionnaire.
Primary outcomes of the study include: (1) SB as sit-
ting time and the number of minutes spent in activities
requiring ≤ 1.5 MET, as objectively measured by hip
worn ActiGraph® accelerometer, and in addition with
ActivPal® (used in Barcelona and Ulm) and Axivity®
(used in Odense and Belfast) accelerometers worn on
the thigh, and as self-reported according to the Patient-
centered Assessment and Counseling for Exercise
(PACE), Sedentary Behavior Questionnaire); and (2)
physical activity as daily CPM and intensity of exercise
performed, as measured by ActiGraph®. Primary and sec-
ondary measures will be collected at the four time
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points. For an overview of primary and secondary out-
comes, outcome measures, instruments and assessment
time points, see Table 2.
Economic evaluation
The health economic evaluation performed alongside
the SITLESS clinical trial will be integral to the main
RCT, providing useful guidance upon the cost-
effectiveness of the intervention. It will be conducted
following NICE [41] recent economics method guidance
for the implementation of the cost-effectiveness analysis,
as well as CHEERS guidelines for the reporting of the re-
sults [42, 43].
Being a population health intervention conducted in a
multi-country setting, the health economic evaluation of
the SITLESS intervention poses specific additional chal-
lenges related to the evaluation of complex public health
interventions of this type [44] as well as to the multi-
country nature of the intervention.
The costs of providing the ERS enhanced by SMSs
(the ‘intervention’ costs) will be identified from a na-
tional health service/publicly funded and personal social
services perspective alongside potential cost impacts
Fig. 1 Schedule of SITLESS interventions
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(costs incurred as well as cost savings) including hospita-
lisations, accident and emergency visits, appointments
with health professionals (health visitor, general practi-
tioner contacts) as well as personal social services (i.e.
social services and community care).
An economic logic model will be developed to systemat-
ically identify all relevant costs and cost savings as well as
to identify potential longer term cost impacts. Following a
multi-country costing approach, costs will be evaluated
using country-specific unit cost estimates weights; further-
more, costs will be translated into a common currency by
using the PPP statistic reported by OECD. Unit cost data
will be identified from routine country-specific sources:
NHS Reference Costs, PSSRU (UK); InEK - Institute for
the Hospital Remuneration System (Germany); Health
Department of Catalonia (Spain); Danish National Health
Register (Denmark) in order to use country-specific price
weights. Furthermore, cross-country comparability be-
tween data sources will be checked.
As for the outcomes, self-reported health-related
quality-adjusted life-years (QALYs) will be obtained
using the EQ-5D-5 L EuroQol [45, 46] instrument as
well as the newly developed capabilities measure of out-
comes for older people, the ICECAP-O instrument [47].
The multinational aspect of the analysis requires the use
of country-specific tariffs, which reflect country-specific
differences in health perceptions and preferences and
might severely affect Cost-Utility analysis [48–50]. When
available, country-specific tariffs will be used to evaluate
health outcomes.
The within trial analysis will explicitly take the multi-
country nature of the SITLESS trial into account, by
using appropriate methodologies as suggested by the
most recent literature and best practices. The multi-
national feature of the SITLESS trial implies a hierarch-
ical structure of the data and unobserved heterogeneity
between clusters that needs to be adequately modelled
with appropriate statistical and econometric techniques
[51, 52]. Following best practice approaches [53–55] a
multiple imputation procedure using chained equations
(MICE) will be used to impute missing data separately
for each arm of the trial.
Within-trial results will be reported and presented as
an incremental cost-utility ratio with the joint distribu-
tion of cost/utility pairs being represented on the cost-
effectiveness plane and with a cost-effectiveness accept-
ability curve (CEAC) [56].
The within-trial economic evaluation results will be
combined with evidence from the literature linking
short-term outcomes with longer-term outcomes to pro-
duce a long-term cost-effectiveness decision analytic
model. A Markov model will be the envisaged analytic
tool to evaluate population health interventions and to
examine outcomes over an extended period of time and
it will be developed alongside Frew et al. [57] and Roux
et al. [58]. However, given that such long-term impacts
Fig. 2 SPIRIT figure
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Table 2 Overview of outcomes, outcome measures, instruments and assessment time points
Outcomes Outcome measures Instrument Assessment
time pointa
Personal information Age, gender, civil status, living
arrangement, educational background,
medical conditions, and smoking
and alcohol habits.
Primary care records
Self-report
T0
Primary outcomes
Sedentary behaviour Sitting time and the number of
minutes spent in activities
requiring ≤ 1.5 Metabolic
Equivalent Tasks.
Actigraph®
ActivPal®
Axivity®
Sedentary Behavior
Questionnaire
T0, T1, T2, T3
Physical activity Daily counts per minute and
intensity of exercise,
and daily step counts.
Actigraph® T0, T1, T2, T3
Secondary outcomes
Physical function General function Aerobic
capacity Static balance
SPPB
2-minutes’ walk test
Unipedal stance
T0, T1, T2, T3
Muscle function Handgrip strength Takei analogue Hand
Grip Dynamometer
T0, T1, T2, T3
Mean strength and power
with concentric contraction
of isoinertial movement
performing 3 exercises: (a) 30-s
chair stand rise; (b) five repetitions
of arm curl with both hands
using a 2-kg and 4-kg weight;
and (c) four counter-movement jumps.
Linear encoder
Health economics’
related outcomes
Use of sport services, and use
of health and social services,
medications, number of falls.
Interview T0, T1, T2, T3
Anthropometry Weight, height, body mass
index, waist and hip circumference.
T0, T1, T2, T3
Bioimpedance % fat; % muscle Tanita BC 420S MA
bioimpedance analyser
T0, T1, T2, T3
Blood pressure Systolic and diastolic blood
pressure; heart rate.
OMRON M6 comfort T0, T1, T2, T3
Activities of Daily Living 6-item questionnaire T0, T1, T2, T3
Self-rated health and
health-related quality of life
SF-12
EUROQOL-5D
ICECAP-O
T0, T1, T2, T3
Anxiety HADS T0, T1, T2, T3
Depressive symptoms HADS T0, T1, T2, T3
Social network Lubben Social Network Scale-6 T0, T1, T2, T3
Physical activity
self-regulation
12-item Physical Activity
Self-Regulation Scale
T0, T1, T2, T3
Self-efficacy for exercise Marcus’s Self-Efficacy
Questionnaire
T0, T1, T2, T3
Disability Short form Late Life Function
and Disability Index
T0, T1, T2, T3
Fear of falling Short Falls Efficacy
Scale – International
T0, T1, T2, T3
Loneliness Short form De Jong Gierveld
Loneliness Scale
T0, T1, T2, T3
Executive function Trail Making Test T0, T1, T2, T3
Physical fatigue Pittsburg Fatigability Scale T0, T1, T2, T3
In a subsample:
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are likely to be reliant on some untestable assumptions,
the model will comprise a detailed sensitivity analysis to
explore how cost-effectiveness will vary within all realis-
tic ranges of costs and outcomes.
As recommended by the UK’s NICE guidance on eco-
nomic evaluation of population health interventions an
annual population health discount rate of 1.5% will be
applied to costs and outcomes.
Ancillary blood and muscle sub-studies
Two sub-studies will be performed to further elucidate
possible mechanistic pathways between SB, PA and our
primary and secondary outcomes. Biomarkers will be
assessed at baseline and after intervention in blood sam-
ples and only after the intervention in muscle biopsies.
Subproject A
Subproject A is an analysis of changes in established
core blood biomarkers associated with the intervention.
This exploratory sub-study will analyse blood samples
from 456 participants (95 participants per arm from two
interventional sites n = 570, considering 20% loss of
follow-up n = 456). Blood will be drawn from partici-
pants at baseline (T0) and at T1 to explore whether the
intervention modifies established and accessible blood
biomarkers (IL-6, hsCRP, TNF-alpha, IGF-1, WBC, RBC,
platelets). Irrespective of the study arm, all participants
with an improvement in PA will be analysed and com-
pared to those without improvement in PA.
Subproject B
Subproject B is an analysis of post-intervention effects
on muscle fibres or muscle tissue components in older
adults. This exploratory sub-study will analyse muscle
tissue from 60 participants to generate hypotheses on
potential effects of reducing SB on muscle tissue. The
muscle biopsy will be performed at week 21 (after asses-
sing the post-intervention activity level with accelerome-
ters) from a biopsy specialist and biomarkers will be
assessed (Myostatin, IL-8, IL-15, VEGF, BDNF, FGF21,
irisin, Type 2/Type 1 fibre ratio, Wnt and Notch signal-
ling, CDC42). In this exploratory analysis, the physical
activity profile or the sedentary profile from baseline
assessment and of the post-intervention period, respect-
ively, will be used as a main exposure marker to be ana-
lysed in relationship to the various biomarker
measurements. Beside descriptive and summary mea-
sures we will use a multivariable analysis approach to
quantify the relationship, and simultaneously adjusting
for potential confounders such as age, gender and co-
morbidities.
Process evaluation
SITLESS follows the guidance on ‘Process evaluation of
complex interventions’ from the Medical Research
Council (MRC) for conducting the process evaluation of
the study [59]. It was applied in the feasibility study to
understand the feasibility of the recruitment strategy
and of the SMS intervention and, hence, optimise its de-
sign and evaluation for the full trial.
The process evaluation of the full trial will be coordi-
nated by a non-intervention site and is aimed at provid-
ing greater confidence in conclusions about effectiveness
of the intervention by assessing: (1) the quantity and
quality of what was delivered (implementation) regard-
ing the PA and the SMSs interventions; and (2) the gen-
eralisability by understanding the role of context.
Moreover, the process evaluation will help to understand
the mechanisms of impact.
All intervention sites will combine their findings to
gain a greater understanding of how the SMSs and the
PA interventions are implemented and the extent to
which they work. Methodologically, basic quantitative
measures of implementation such as fidelity and adher-
ence will be combined with qualitative data, including
observation on sessions, focus groups and interviews
with a purposeful sample of participants with different
profiles. Moreover, the sessions on monitoring and sup-
port of the SMSs instructors will be used to gather fur-
ther information on implementation challenges.
Research teams will provide context information on each
intervention site.
Qualitative and quantitative findings will be triangulated
according to a standardised protocol that will entail: (1)
sorting themes and following threads; and, where relevant,
(2) seeking convergence, complementarity, silence and
Table 2 Overview of outcomes, outcome measures, instruments and assessment time points (Continued)
Level of frailty-associated
biomarkers and inflammation
IL-6, hsCRP, TNF-alpha, IGF-1. Blood sample T0, T1
Sarcopenia-associated
markers of muscle quality
Myostatin, IL-6, IL-8, IL-15,
VEGF, BDNF, FGF21, irisin,
myostatin, Type 2/Type 1
fibre ratio, Wnt and
Notch signaling, CDC42
Muscle biopsy T1
aAssessment time points: T0 = baseline pre-intervention, T1 = at month 4 post intervention, T2 = at month 16 (12 months after the end of the inter-
vention), and T3 = at month 22 (18 months after the end of the intervention)
SPPB Short Physical Performance Battery, ICECAP-O ICEpop CAPability measure for Older people, HADS Hospital Anxiety and Depression Scale
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dissonance in themes, looking for either full or partial
agreement or disagreement across the methods [60]. Our
methods will follow best practice reporting guidelines for
qualitative studies [61].
Data and statistical analysis
The full analysis set will follow the intention-to-treat
principle and will include all randomised participants for
whom a baseline assessment is conducted, regardless of
later temporary or permanent loss to follow-up, with-
drawal or drop-out of the study.
The study hypothesis will be tested with mixed linear
models with repeated measures, to assess changes in
main outcomes (SB and CPM) over time (T0 to T3) and
between-study arms. A diagonal matrix design will be
considered for the within-participants covariance matri-
ces (covariance structure for repeated measures factors).
Fixed effects in the analyses will be treatment group and
country (study site), the latter based on its relevance as
proxy for intervention and cultural differences. Random
effects may be considered for the ERS + SMS group and
ERS group, to take into account within-study clustering.
A diagonal matrix design will be considered for the
between-participants covariance matrices (covariance
structure for random factors). The between-participants
correlations induced by randomisation by centre and the
clustering of cohabiting individuals will be taken into ac-
count in the models. Further testing of the study hy-
potheses will be conducted through covariance analyses,
including in the model relevant covariates (age, gender,
BMI, SPPB level and frailty), and effect modifiers.
Secondary analyses will be conducted to explore
changes over time in the relative efficacy of the interven-
tions. Mixed linear models with repeated measures will
be built to assess changes over time between interven-
tion groups in main and secondary variables, at baseline
(T0) and T1, T2 and T3. Interaction terms between
treatment and time will be considered to test for differ-
ences over time between treatments.
A sensitivity analysis will be conducted, restricted to
the ‘per protocol’ dataset, comprising all participants
with no protocol violations and complete (e.g. no miss-
ing data) measurements for the primary variables for all
study assessments (baseline, end of treatment, first
follow-up, second follow-up). A second sensitivity ana-
lyses will be conducted for any primary variable with a
substantial number of missing values (higher than 5%),
imputing missing data by the ‘last observation carried
forward’ method.
No subgroup analyses are planned in advance. Any
subgroup analysis conducted will be treated with caution
and output will be treated as exploratory rather than de-
finitive. Missing data will be imputed through a multiple
imputation approach, imputing missing values with the
corresponding average values from the set of partici-
pants in the control group in the same country as the
participant, matched for age, gender, baseline PA and
baseline SPPB score.
Two-sided tests of statistical significance will be used in
all statistical analyses. Estimates of the size of treatment
effects will be presented together with confidence inter-
vals, in addition to significance tests. Significance levels
will be set to a 5% level, applying the Bonferroni correc-
tion to adjust for type I error criteria. All analyses will be
performed with SPSS version 20 or Stata version 12.
Discussion
This study provides a protocol for a multicentre prag-
matic RCT to assess the effectiveness of existing ERS en-
hanced by SMSs to reduce SB, increase PA and improve
health, quality of life, function and psychosocial out-
comes in the long term (22 months) in older adults in-
cluded in four European countries.
Currently, numerous RCTs have assessed the effects of
PA-based interventions to improve health outcomes
[21]. However, interventions aimed at reducing SB in
older adults have only begun to emerge. There is grow-
ing evidence on how to promote healthier habits
through SMSs based on behavioural interventions, but
the integration of this knowledge into one complex and
pragmatic RCT is a novel approach, as well as the ex-
pected impact in the long term. The foundation of this
study is the existing ERS, which are implemented across
Europe, but the adherence of professionals and older
adults to ERS appears to be relatively poor. Therefore,
SITLESS aims to impact health policy-makers with
evidence-based knowledge to improve existing ERS by
making them more effective.
Several national and international public health guide-
lines explicitly recommend that older adults should re-
duce their sedentary time and break prolonged periods
of sitting to promote healthy ageing and wellbeing [62].
However, to date, few studies have investigated determi-
nants of sitting and barriers and facilitators to change SB
in older adults [63, 64]. Studies have reported determi-
nants, barriers and facilitators specific to sitting that are
different from those for PA. This might be due to the
unique nature of SB, which occurs continuously during
the day, compared to finite and set periods of PA or ex-
ercise occurring during the week. This suggests that in-
terventions to reduce SB need to be specifically
integrated into daily life.
When designing interventions to reduce SB and in-
crease PA levels, rather than solely focusing on activities
of at least moderate intensity, there is emerging evidence
that replacing sitting time with standing or light PA may
also provide substantial public health benefits [10, 65].
Some researchers had recognised that many older adults
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find it difficult to meet the PA guidelines of ≥150 min of
moderate PA per week [66]. Therefore, a theoretic advan-
tage of the SITLESS study is that promoting light PA may
maximise the likelihood of people increasing their volume
of PA along the continuum to a higher PA level [67].
Older adults are often unaware of exactly how long,
where, when and why they sit [64]. Comparisons be-
tween self-reported and objective measures of SB have
shown that older adults underestimate the time they
spend sitting [16]. In the SITLESS trial, a combination
of self-report and objective measures will be used. More-
over, the intervention itself pretends rising awareness on
SB among participants.
The findings of this study will help inform the design of
more effective interventions to reduce SB and increase PA
levels, and hence improve health outcomes in the older
adult population in the long term. The results of the
present study may help to assist policy-makers of different
European countries in deciding how or whether this inter-
vention should be implemented widely or restructured.
Study limitations
The SITLESS study faces an important challenge on
how to standardise ERS and SMSs interventions across
four European countries with different healthcare path-
ways. However, this is the first large RCT comparing
ERS and ERS enhanced with SMSs to reduce SB in older
adults, assessing many validated and objective outcome
measures. SITLESS incorporates a process evaluation
procedure throughout the trial providing greater confi-
dence in conclusions about effectiveness.
Trial status
This initial phase of this project commenced in May
2015. A feasibility study was performed from December
2015 until June 2016. The recruitment for the trial
started in July 2016. At the time of submission of this
protocol, less than 250 participants have been included
in the study over a six-month recruitment period. To
date, none of the participants have completed the inter-
vention and no adverse events have been reported.
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